Locations:
Search
Proteins related to altered immune response are potential biomarkers of the rare AD variant
Real-world claims data and tissue culture studies set the stage for randomized clinical testing
For some older adults, a rural setting in late life may be protective
New findings have important implications for clinical trial design
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Studying brain samples can advance understanding of mechanisms and impact clinical care
New insights into shared inflammatory pathways and immune responses
Alzheimer’s, Lewy body and other etiologies have distinct presentations and treatments
TNFRSF1B gene variant associated with slower progression, offering potential drug target
An update on biomarkers and various therapies in development
Cohort study characterizes symptomatology by Alzheimer’s and Lewy body pathology
Advertisement
Advertisement